Biliary Tract Neoplasms Completed Phase 2 Trials for Osemitamab (DB18219)

Also known as: Biliary Tract Neoplasm / Neoplasm biliary tract / Biliary neoplasm NOS / Biliary neoplasm / Neoplasm of biliary tract (disorder) / Biliary neoplasia

IndicationStatusPhase
DBCOND0032430 (Biliary Tract Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05190575TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract CancerTreatment